Founder of the Regenerative SportsCare Institute Announces the Launch of New Book, Heal Your Disc, End Your Pain

07 Feb 2023
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Dr. Gregory Lutz, Founder and Chief Medical Officer of the Regenerative SportsCare Institute (RSI), is pleased to announce the launch of the new book Heal Your Disc, End Your Pain: How Regenerative Medicine Can Save Your Spine.
Dr. Lutz began his medical career determined to find better solutions for patients suffering from degenerative disc disease. His pursuit led him to the discovery of a simple root cause regenerative medicine treatment that can provide life-changing relief for many patients.
Continue Reading
Dr. Lutz shares his method for safely treating patients with chronic low back pain without drugs or surgery.
Tweet this
Now, in Heal Your Disc, End Your Pain, Dr. Lutz shares his method for safely treating patients with chronic low back pain without drugs or surgery. He also explains why many methods for managing back pain fail because they do not address the root causes, and shows how a simple one-time remedy can give patients long-term results.
"Chronic lower back pain is usually nothing more than an unhealed wound in your disc, which can be treated simply and effectively with your own cells," Dr. Lutz said. "I wrote Heal Your Disc, End Your Pain to share this knowledge, because I believe it will help many people finally find an answer to their chronic lower back pain."
Heal Your Disc, End Your Pain released on February 7th and is available on Amazon and at other major retailers.
Note to Editors:
Dr. Gregory Lutz is the Founder and Chief Medical Officer of the Regenerative SportsCare Institute, Physiatrist-in-Chief Emeritus at Hospital for Special Surgery, and a professor of clinical rehabilitation medicine at Weill Medical College of Cornell University. A pioneer in regenerative medicine, Dr. Lutz has co-authored more than sixty scientific publications, including the first double-blind, randomized, controlled study demonstrating the clinical efficacy of intradiscal platelet-rich plasma therapy. Dr. Lutz is the Co-Founder and Executive Chairman of Orthobond Corporation.
CONTACT INFORMATION:
Kelly Teemer
702-335-1558
[email protected]
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.